CoStim Pharmaceuticals
Acquired- Business Model
- B2B
- Last Round
- Series AJan 2013
- Rounds
- 2
About
Novel antibodies for immuno-oncology
Summary
CoStim Pharmaceuticals is a Biotech company. Its most recent funding was a Series A round in Jan 2013. Investors include MPM Capital, Novartis and Atlas Venture.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2014
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company